Keyword Connections

•  Angela Jefferson
•  Bernard Rousseau

•  Deborah Murdock
•  Nathan Brummel

Resources

• Expedited Phenotyping

Communities

• No matching connections

Publications

• Genetic determinants of response to warfarin during initial anticoagulation.
  Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM
  (2008) N Engl J Med 358: 999-1008
• Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.
  Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA
  (2008) N Engl J Med 358: 1109-17
• Percent emphysema, airflow obstruction, and impaired left ventricular filling.
  Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE
  (2010) N Engl J Med 362: 217-27
• Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
  Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Hersey P, Kefford R, Lawrence D, Puzanov I, Lewis KD, Amaravadi RK, Chmielowski B, Lawrence HJ, Shyr Y, Ye F, Li J, Nolop KB, Lee RJ, Joe AK, Ribas A
  (2012) N Engl J Med 366: 707-14
• Atypical antipsychotic drugs and the risk of sudden cardiac death.
  Ray WA, Chung CP, Murray KT, Hall K, Stein CM
  (2009) N Engl J Med 360: 225-35
• Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
  Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ
  (1995) N Engl J Med 332: 1198-203
• The index case for the fungal meningitis outbreak in the United States.
  Pettit AC, Kropski JA, Castilho JL, Schmitz JE, Rauch CA, Mobley BC, Wang XJ, Spires SS, Pugh ME
  (2012) N Engl J Med 367: 2119-25
• Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy.
  Ray WA, Daugherty JR, Meador KG
  (2003) N Engl J Med 348: 1885-94
• Oral erythromycin and the risk of sudden death from cardiac causes.
  Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM
  (2004) N Engl J Med 351: 1089-96
• Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?
  White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML
  (1984) N Engl J Med 310: 819-24
• The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.
  Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB
  (1997) N Engl J Med 336: 912-8
• Antidepressants and the risk of falls among nursing home residents.
  Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA
  (1998) N Engl J Med 339: 875-82
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
  Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ, Global ARCC Trial
  (2007) N Engl J Med 356: 2271-81
• Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.
  FitzGerald GA, Smith B, Pedersen AK, Brash AR
  (1984) N Engl J Med 310: 1065-8
• Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients.
  Smalley WE, Griffin MR, Fought RL, Sullivan L, Ray WA
  (1995) N Engl J Med 332: 1612-7
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
  Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project
  (2002) N Engl J Med 346: 1937-47
• Three months of rifapentine and isoniazid for latent tuberculosis infection.
  Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, TB Trials Consortium PREVENT TB Study Team
  (2011) N Engl J Med 365: 2155-66
• Reversible cardiomyopathy associated with sunitinib and sorafenib.
  Uraizee I, Cheng S, Moslehi J
  (2011) N Engl J Med 365: 1649-50
• Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature.
  Roberts LJ, Marney SR, Oates JA
  (1979) N Engl J Med 300: 236-8
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
  Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS
  (2004) N Engl J Med 350: 655-63
• High-dose corticosteroids in patients with the adult respiratory distress syndrome.
  Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA
  (1987) N Engl J Med 317: 1565-70
• Evaluating drugs after their approval for clinical use.
  Ray WA, Griffin MR, Avorn J
  (1993) N Engl J Med 329: 2029-32
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
  Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH
  (1988) N Engl J Med 318: 869-76
• Tolvaptan in patients with autosomal dominant polycystic kidney disease.
  Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators
  (2012) N Engl J Med 367: 2407-18
• Estrogen therapy and coronary-artery calcification.
  Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML, WHI and WHI-CACS Investigators
  (2007) N Engl J Med 356: 2591-602